A Tribute to Sean M. Healey
Two years ago, Sean M. Healey became a part of the Mass General ALS family and an advocate for those with ALS. We are saddened to share the news that Sean M. Healey, our treasured partner, patient and friend passed away peacefully May 26, 2020 with his loving family by his side.
COVID-19 Impacts on HEALEY ALS Platform Trial
We are closely monitoring the impact of COVID-19 on the HEALEY ALS Platform Trial timeline. We are committed to starting as soon as we can do so safely, and hosted a webinar on April 8th to update you on our progress and answer as many questions as possible.
Accelerating Discovery with the HEALEY ALS Platform Trial
Borrowing from successes in cancer drug development, Healey Center and NEALS faculty are leading the first ALS Platform Trial.
Igniting Innovation Through Research & Trials
The Healey Center for ALS unites the world’s leading experts to revolutionize how treatments are developed for people with amyotrophic lateral sclerosis (ALS). We support and accelerate groundbreaking, innovative global clinical trials for all people with ALS.